Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Celestica Inc (CLS) vs Smith & Nephew plc (SNN) Price & Performance

Celestica IncTrade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

Celestica Inc vs Smith & Nephew plc — how do they compare? Celestica Inc trades at $315.93 (market cap $39.16B), while Smith & Nephew plc trades at $30.05 (market cap $12.54B). The key difference: Celestica Inc is far larger — about 3.1× Smith & Nephew plc's market cap, and Smith & Nephew plc pays a 2.65% dividend while Celestica Inc pays none. Which is the better fit depends on your goals.

CLSSNN
Market Cap
$39.16B$12.54B
Sector
TechnologyHealth
52-Week High
$472.40$38.70
52-Week Low
$181.34$28.73
Enterprise Value
$39.44B$15.57B
Dividend Yield
2.65%

Returns comparison

Trailing returns across standard periods

About Celestica Inc

Celestica provides supply chain and manufacturing solutions for global technology companies. It specializes in high-complexity assembly and platform solutions for AI data centers, aerospace, and medical markets.

Read more on CLS

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN